Loading…
Formulation Optimization and In-vitro Evaluation of Oral Floating Captopril Matrix Tablets using Factorial Design
Purpose: To develop a zero-order sustained release floating formulation of captopril, and optimize its drug release for enhanced oral bioavailability. Methods: A relatively new approach, 32 full factorial design, was used to formulate floating captopril matrix tablets and to systematically optimize...
Saved in:
Published in: | Tropical journal of pharmaceutical research 2015-10, Vol.14 (10), p.1737 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Purpose: To develop a zero-order sustained release floating formulation
of captopril, and optimize its drug release for enhanced oral
bioavailability. Methods: A relatively new approach, 32 full factorial
design, was used to formulate floating captopril matrix tablets and to
systematically optimize its drug release using varying levels of
xanthan gum and hydroxypropyl methylcellulose (HPMC) K100M polymers.
Calcium carbonate was used as gasgenerating agent. After setting the
levels by preliminary trials, nine tablet formulations (F1 - F9) were
prepared by wet granulation method using Design Expert Software® -
suggested combinations of polymers. The concentrations of HPMC K100M
(X1) and xanthan gum (X2) were chosen as control variables. Conversely,
the response variables selected were timed to release 50 % of the drug
(t50%) at 6 h (Q6) and 12 h (Q12). Fourier transform infrared (FTIR)
spectroscopy and differential scanning calorimetry (DSC) were used to
assess compatibility between the drug and the excipients. The validity
of the developed mathematical equations was assessed by designing three
extra check-points. Results: The response surface plots drawn
demonstrated the suitability of the hydrophilic matrixforming agents
for formulating controlled release floating tablets of captopril. FTIR
and DSC spectra showed no noticeable incompatibility between drug and
polymers in both physical mixtures and in formulations. Floating time
lag remained < 5.5 min with floating duration > 12 h.
Considerable agreement was observed between predicted and actual
release parameters. Fitting the data into different kinetic models
showed that non-Fickian behavior for diffusion exponent (n) differed
from 0.588 and 0.811. Conclusion: Optimum formulation (F4) showed
satisfactory release profile. Moreover, the study successfully
demonstrated influence of polymer blends in controlling release
variables. |
---|---|
ISSN: | 1596-5996 1596-9827 |
DOI: | 10.4314/tjpr.v14i10.2 |